[Federal Register Volume 67, Number 90 (Thursday, May 9, 2002)]
[Notices]
[Page 31351]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-11521]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; Assessment of the Use 
of Special Funding for Research on Type 1 Diabetes Provided by the 
Balanced Budged Act of 1997 and the FY 2001 Consolidated Appropriations 
Act.

SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK), the National Institutes of Health (NIH) 
has submitted to the Office of Management and Budget (OMB) a request 
for review and approval of the information collection listed below. 
This proposed information collection was previously published in the 
Federal Register on November 28, 2001, page 59438 and allowed 60 days 
for public comment. No public comments were received. The purpose of 
this notice is to allow an additional 30 days for public comment. The 
National Institutes of Health may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.

Proposed Collection

    Title: Assessment of the Use of Special Funding for Research on 
Type 1 Diabetes Provided by the Balanced Budget Act of 1997 and the FY 
2001 Consolidated Appropriations Act. Type of Information Collection 
Requested: NEW. Need and Use of Information Collection: This survey 
will be one source of input into a statutorily mandated assessment and 
report to the Congress on special funding for research on type 1 
diabetes provided by 42 U.S.C. 254c-2 and 42 U.S.C. 1254c-2 note, 
``Special Diabetes Program for Type 1 Diabetes'' (as created by the 
Balanced Budget Act of 1997, Pub. L. 105-33, and amended by the FY 2001 
Consolidated Appropriations Act, Pub. L. 106-554). The primary 
objective of this study is to gain information, via a brief 
questionnaire, from NIH research grantees who were the primary 
recipients of these special funds. The responses will provide valuable 
information concerning how the funds have facilitated research as 
intended by these Acts of the Congress. Information from this study 
will aid in evaluation of the process by which the research goals for 
use of the special type 1 diabetes funds have been developed and are 
being pursued. Responses from this study will contribute to a 
statutorily mandated report, due to the Congress on January 1, 2003 (42 
U.S.C. 254c-2 and 42 U.S.C. 1254c-2 note), evaluating the process and 
efforts under this program and assessing research initiatives funded by 
these Acts of the Congress. Frequency of Response: The initial survey 
will require a one time response; though, respondents may be contacted 
again in the event of future congressionally mandated reports on the 
use of the special type 1 diabetes research funds. Affected Public: 
Research scientists who received the special funds about which the 
Congress has mandated in law the requirements for an evaluation report. 
Type of Respondents: Laboratory and clinical investigators who have 
received support from the special type 1 diabetes funds provided under 
the laws previously cited. The annual reporting burden is as follows: 
Estimated number of respondents: 300; Estimated Number of Responses per 
Respondent: 1; Average Burden Hours per Response: 1 hour for nine 
questions; and Estimated Total Burden Hours Requested: 300. The 
annualized total cost to respondents is estimated at: $15,000. It is 
expected that the respondents will be contacted and will return their 
responses via electronic mail. These measures will reduce the burden on 
the respondents and the overall costs of administering the study. 
Respondents will be asked to answer nine questions, one-third of which 
will be answered with ``yes'' or ``no'' or a one-word response. There 
are no Capital Costs, Operating Costs or Maintenance Costs to report.

Request for Comments

    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) the accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) ways to minimize the burden of the 
collection of information one those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.

Direct Comments to OMB

    Written comments and/or suggestions regarding the item(s) contained 
in this notice, especially regarding the estimated public burden and 
associated response time, should be directed to the: Office of 
Management and Budget, Office of Regulatory Affairs, New Executive 
Office Building, Room 10235, Washington, DC 20503, Attention: Desk 
Officer for NIH. To request more information on the proposed project or 
to obtain a copy of the data collection plans and instruments, contact: 
Dr. Michelle A. Cissell, AAAS/NIH Science Policy Fellow, Office of 
Scientific Program and Policy Analysis, NIDDK, NIH, Building 31, Room 
9A11, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free 
number (301) 496-6623 or e-mail your request, including your address 
to: [email protected].

Comments Due Date

    Comments regarding this information collection are best assured of 
having their full effect if received within 30 days of the date of this 
publication.

    Dated: April 22, 2002.
Barbara Merchant,
Executive Officer, NIDDK.
[FR Doc. 02-11521 Filed 5-8-02; 8:45 am]
BILLING CODE 4140-01-M